Microscopic examination of fetal placenta exposed to <i>U.simensis</i> essential oil: D-decidua, DA-decidual artery, DV-decidual vein, blue arrow head-maternal blood space, CBV-cho... by Bickes Wube (21678222)

Subjects:

External examination of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Histopathological scoring of fetal placenta exposed to <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Chemical compositions of <i>U.simensis</i> essential oil identified through GC-MS analysis. by Bickes Wube (21678222)

Subjects:

Axial and extremity bone ossification centers of rat fetuses treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal outcomes of gravid rats treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal growth, anogenital distance and placental weight of rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Developmental scores of cardiovascular and musculoskeletal systems of rat embryos treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Dietary intake and weight gain of pregnant dams treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Implantation and resorption of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil I-implantation, R-resorption, TR-total resorption only in one gravid rat, O-ovary... by Bickes Wube (21678222)

Subjects:

In vivo development of 12-day old rat embryos treated with <i>U.simensis</i> essential oil: VV – vitelline blood vessels, YS-yolk sac, TE- telencephalon, ME-mesencephalon, PA-phary... by Bickes Wube (21678222)

Subjects:

Skeletal ossification of alizarin red stained 20-day old rat fetuses treated with <i>U.simensis</i> essential oil: TL-thoracic and lumbar vertebrae, O-occipital bone, MC-metacarpal... by Bickes Wube (21678222)

Subjects:

All raw data support findings of the study. by Bickes Wube (21678222)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). by Amoura M. Abou-El-Naga (21001524)

CFU counts and calculations. by Nykki D. Ross (20933968)

Subjects:

Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories. by Zhi Jin (3742471)

Subjects:

Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups. by Zhi Jin (3742471)

Subjects:

Growth of Sf14 in various media. by Nykki D. Ross (20933968)

Subjects: